Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/30266
Title: Using heart rate data from wrist worn activity trackers to define thresholds for moderate to vigorous physical activity in children and young people with cystic fibrosis
Authors: Tanriver, G
Stanojevic, S
Filipow, N
Douglas, H
Raywood, E
Kapoor, K
Davies, G
Murray, N
O'Connor, R
Robinson, E
Main, E
Keywords: children and young people;cystic fibrosis;moderate-to-vigorous physical activity;activity tracker;heart rate threshold;linear mixed-effects model;reference equation
Issue Date: 6-Nov-2024
Publisher: Elsevier on behalf of European Cystic Fibrosis Society
Citation: Tanriver, G. et al. (2024) 'Using heart rate data from wrist worn activity trackers to define thresholds for moderate to vigorous physical activity in children and young people with cystic fibrosis', Journal of Cystic Fibrosis, 0 (in press, corrected proof), pp. 1 - 6. doi: 10.1016/j.jcf.2024.10.014.
Abstract: Background: Children and young people with cystic fibrosis (CYPwCF) are encouraged to do an average of 60 min of moderate-to-vigorous physical activity (MVPA) daily. However, there are no agreed heart rate (HR) thresholds for defining MVPA, so it is difficult to ascertain whether these targets are actually achieved. Wearable activity trackers enable continuous monitoring of fitness-related measures such as HR and could be used to measure duration and intensity of habitual MVPA. We aimed to define personalized and responsive MVPA thresholds from HR in CYPwCF, to determine habitual time spent in MVPA during childhood and adolescence. Methods: Continuous daily HR data were collected from 142 CYPwCF wearing activity trackers over 16 months. Linear mixed-effects models were used to develop personalised estimates of resting heart rate (RHR), peak heart rate (PHR) and MVPA thresholds, which were defined using the American College of Sports Medicine heart rate reserve (HRR) method. Results: 309,926 days of physical activity data showed that both RHR and PHR declined with age in CYPwCF, with considerable variability within and between individuals. The HRR method produced personalised MVPA thresholds for each CYPwCF based on age, which inherently accounted for individual demographic variability and personal factors such as cardiovascular fitness or disease severity. Conclusions: By accounting for within and between person variability in RHR and PHR, our novel method provides more accurate age-related personalised MVPA thresholds for CYPwCF than existing estimates. Our findings provide population-based estimates for RHR, PHR and MVPA thresholds at different ages in CYPwCF. This approach may help guide development of international standards for objective MVPA measurement in the era of remote HR and activity monitoring and facilitate accurate measurement of habitual physical activity in children and young people.
Description: Highlights: • Aging, illness and fitness will influence resting and peak heart rates in children. • Moderate-vigorous physical activity thresholds vary with age, illness and fitness. • Personal heart rate thresholds for moderate physical activity in children with CF. • Age-based resting, moderate activity and peak heart rate threshold references. • Personal heart rate thresholds for assessing habitual activity in children with CF.
URI: https://bura.brunel.ac.uk/handle/2438/30266
DOI: https://doi.org/10.1016/j.jcf.2024.10.014
ISSN: 1569-1993
Other Identifiers: ORCiD: Sanja Stanojevic https://orcid.org/0000-0001-7931-8051
ORCiD: Nicole Filipow https://orcid.org/0000-0003-3544-6136
ORCiD: Helen Douglas https://orcid.org/0000-0002-5184-6300
ORCiD: Emma Raywood https://orcid.org/0000-0002-0993-5115
ORCiD: Gwyneth Davies https://orcid.org/0000-0001-7937-2728
ORCiD: Nicky Murray https://orcid.org/0009-0007-4073-7241
ORCiD: Elisabeth Robinson https://orcid.org/0000-0002-0528-0561
ORCiD: Eleanor Main https://orcid.org/0000-0002-9739-3167
Appears in Collections:Dept of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2024 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society. This is an open access article under a Creative Commons license (https://creativecommons.org/licenses/by/4.0/).1.31 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons